USTCX Mutual Fund Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

USTCX Analyst Rating

Strong Buy

233 Buy

31 Hold

0 Sell

Based on the consensus analyst ratings on 264 stocks held in USTCX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

USTCX Analyst Price Target

Average Price Target

$34.25

Based on 264 Wall Street analysts offering 12 month price targets to USAA Science & Technology Fund Class A holdings in the last 3 months. The average price target is $34.25 with a high forecast of $43.79 and a low forecast of $24.74. The average price target represents a 38.50% change from the last price of $24.73.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"$21","44":"$44","26.75":"$26.8","32.5":"$32.5","38.25":"$38.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43.785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$43.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.251,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$34.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.74</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,26.75,32.5,38.25,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.48,26.888076923076923,28.296153846153846,29.70423076923077,31.11230769230769,32.520384615384614,33.928461538461534,35.33653846153846,36.744615384615386,38.152692307692305,39.560769230769225,40.96884615384615,42.37692307692308,{"y":43.785,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.48,26.154692307692308,26.829384615384615,27.504076923076923,28.17876923076923,28.853461538461538,29.528153846153845,30.202846153846153,30.87753846153846,31.552230769230768,32.22692307692307,32.90161538461538,33.576307692307694,{"y":34.251,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.48,25.423076923076923,25.366153846153846,25.30923076923077,25.252307692307692,25.195384615384615,25.138461538461538,25.08153846153846,25.024615384615384,24.967692307692307,24.91076923076923,24.853846153846153,24.796923076923076,{"y":24.74,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.82,"date":1714521600000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.1,"date":1717372800000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.5,"date":1719792000000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.45,"date":1722470400000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.93,"date":1725321600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.03,"date":1727740800000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.8,"date":1730419200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.18,"date":1733097600000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.66,"date":1735776000000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.16,"date":1738540800000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.73,"date":1740960000000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.53,"date":1743465600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.48,"date":1746057600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$43.79

Average Price Target$34.25

Lowest Price Target$24.74

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

USTCX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CAMP

CAMP4 Therapeutics Corporation

3 Buy

0 Hold

0 Sell

Strong Buy

$17.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IOVA

Iovance Biotherapeutics

10 Buy

4 Hold

0 Sell

Moderate Buy

$13.83

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GOSS

Gossamer Bio

4 Buy

0 Hold

0 Sell

Strong Buy

$8.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRBP

Corbus Pharmaceuticals Holdings

8 Buy

0 Hold

0 Sell

Strong Buy

$47.14

xxxxxxxxxxxxxxxxxxxxxxxxxxx

OLMA

Olema Pharmaceuticals, Inc.

6 Buy

0 Hold

0 Sell

Strong Buy

$28.00

USTCX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PLTR

Palantir Technologies Inc.

3 Buy

11 Hold

4 Sell

Hold

$98.56

xxxxxxxxxxxxxxxxxxxxxxxxxxx

6990

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H

4 Buy

0 Hold

0 Sell

Strong Buy

$281.95

xxxxxxxxxxxxxxxxxxxxxxxxxxx

YELP

Yelp Inc

1 Buy

5 Hold

2 Sell

Hold

$35.67

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GNS

Genus plc

2 Buy

1 Hold

0 Sell

Moderate Buy

$1,962.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

QLYS

Qualys Inc

3 Buy

8 Hold

3 Sell

Hold

$130.00

USTCX Mutual Fund FAQ

What is USTCX’s average 12-month price target, according to analysts?

Based on analyst ratings, USAA Science & Technology Fund Class A’s 12-month average price target is 34.25.

What is USTCX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for USTCX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is USTCX a Buy, Sell or Hold?

USAA Science & Technology Fund Class A has a consensus rating of Strong Buy which is based on 233 buy ratings, 31 hold ratings and 0 sell ratings.

What is USAA Science & Technology Fund Class A’s price target?

The average price target for USAA Science & Technology Fund Class A is 34.25. This is based on 264 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.79 ,the lowest forecast is $24.74. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about USAA Science & Technology Fund Class A?

USAA Science & Technology Fund Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 264 Wall Streets Analysts.

How can I buy shares of USTCX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing